Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Sales | 5,945,561 | 6,820,964 | 5,573,770 | 5,501,124 | 4,580,465 |
| Cost of Goods | 2,592,011 | 3,275,733 | 2,391,218 | 2,388,613 | 1,759,583 |
| Gross Profit | 3,353,550 | 3,545,230 | 3,182,552 | 3,112,511 | 2,820,882 |
| Operating Expenses | 2,405,936 | 3,778,449 | 2,493,604 | 2,570,347 | 1,778,704 |
| Operating Income | 947,625 | -232,485 | 689,166 | 542,777 | 1,042,761 |
| Interest Expense | 147,542 | 88,832 | 86,884 | 81,683 | 34,948 |
| Other Income | 40,582 | 100,865 | 124,035 | 196,042 | 105,556 |
| Pre-tax Income | 840,665 | -220,452 | 726,317 | 657,136 | 1,113,369 |
| Income Tax | 143,128 | 239,439 | 10,475 | 44,892 | 264,809 |
| Net Income Continuous | 697,537 | -459,891 | 715,842 | 612,244 | 848,560 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 16,323 |
| Net Income | $697,537 | $-476,214 | $715,842 | $612,244 | $864,883 |
| EPS Basic Total Ops | 0.45 | -0.32 | 0.47 | 0.40 | 0.57 |
| EPS Basic Continuous Ops | 0.45 | -0.31 | 0.47 | 0.40 | 0.56 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 0.01 |
| EPS Diluted Total Ops | 0.45 | -0.30 | 0.46 | 0.40 | 0.56 |
| EPS Diluted Continuous Ops | 0.45 | -0.29 | 0.46 | 0.40 | 0.55 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 0.01 |
| EBITDA(a) | $1,380,049 | $178,621 | $1,070,607 | $995,797 | $1,355,944 |